Reference Library

Glossary

A small working vocabulary helps a patient hear the difference between a real answer and a polished deflection.

Use this page for
Clarifying what belongs in a real due-diligence process before a provider narrative gets to define the frame for you.

The language worth keeping close.

COA

Certificate of Analysis

A lot-specific release document that should identify viability, sterility, endotoxin, and release details for the exact product being administered.

GMP

Good Manufacturing Practice

A manufacturing discipline, not a vibe. It governs process control, contamination prevention, documentation, and product release criteria.

BLA

Biologics License Application

The formal FDA approval pathway for biological products. 'FDA registered' is not the same thing.

IND

Investigational New Drug

A regulatory mechanism that allows a trial to proceed under supervision. It does not mean a clinic can charge you as a paying customer in a fake trial.

Allogeneic

From a donor

A product sourced from someone other than the patient. Donor screening, biosafety, and release documentation become especially important.

Autologous

From the patient

A product sourced from the same patient, often marketed as inherently safer. The route, processing, and evidence mismatch questions still matter.